APOL1 and chronic kidney disease: Black patients with two APOL1 risk alleles have a significantly higher risk of CKD progression and end‐stage renal disease (ESRD) compared to those with zero or one risk allele, with a 1.49‐fold increased risk of CKD and a 1.88‐fold increased risk of ESRD.16, 17